Medical Weight Loss for Elyria, Ohio Residents
Elyria, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Elyria through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Elyria Residents Choose New Hope Weight Loss
Elyria patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Ohio and beyond since 2020.
From our Costa Mesa, California practice, we provide Elyria with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
For Elyria, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout downtown Elyria and the greater Lorain County area west of Cleveland. Spanish-speaking Elyria patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Telehealth removes the distance between Elyria and specialized care: your consultation happens wherever you are in Ohio. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Elyria patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Elyria
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Elyria
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Elyria address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Elyria
Does New Hope Weight Loss treat patients in Elyria?
Yes. Although the clinic is in Costa Mesa, California, we treat Elyria, Ohio residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Elyria?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Elyria address in cold-pack packaging.
What do Elyria patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Elyria do you serve?
We serve patients from across Elyria by telehealth, including downtown Elyria and the greater Lorain County area west of Cleveland.
What support is there for side effects for Elyria patients?
Dr. Sharma starts Elyria patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elyria, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.